Mat joined the Tsai lab in 2018 after earning his Ph.D. in Neuroscience from Washington University in St. Louis, where he used cellular reprogramming strategies to study the contribution of aging to neurodegeneration. At MIT, Mat’s research efforts are targeted at modeling Alzheimer’s disease with human brain organoids derived from induced pluripotent stem cells (iPSCs).